SCHEMBL2348770

SCHEMBL2348770

CCS(=O)(=O)c1ccc(OC)c(C(N)=O)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.51
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
DRD2 P14416 2/20 0.50
DRD3 P35462 2/20 0.50
HTR2B P41595 2/20 0.50
KCNH2 Q12809 2/20 0.50
ADRA2B P18089 1/20 0.50
ADRA2C P18825 1/20 0.50
SLC6A4 P31645 1/20 0.50
HRH3 Q9Y5N1 1/20 0.50
MAPK1 P28482 3/20 0.47
LMNA P02545 3/20 0.47
RAB9A P51151 1/20 0.47
FLT1 P17948 1/20 0.47
FLT4 P35916 1/20 0.47
KDR P35968 1/20 0.47
ALDH1A1 P00352 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
KDM4E B2RXH2 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29622774 1.00 GAA (0.51) GAAMEN1KMT2ADRD2DRD3
SCHEMBL10744283 0.88 POLB (0.46) GAADRD2DRD3HTR2BKCNH2
SCHEMBL8544664 0.86 MAPK1 (0.56) GAADRD2DRD3HTR2BKCNH2
SCHEMBL21054952 0.85 GAA (0.56) GAAMEN1KMT2ADRD2DRD3
SCHEMBL10744279 0.84 GAA (0.51) GAAMEN1KMT2ADRD2DRD3
SCHEMBL27631394 0.84 GAA (0.55) GAAMEN1KMT2ADRD2DRD3
SCHEMBL10723820 0.84 DRD2 (0.50) GAADRD2DRD3HTR2BKCNH2
SCHEMBL31038303 0.84 CA2 (0.52) GAAMEN1KMT2AMAPK1ALDH1A1
SCHEMBL30219287 0.84 SMN1; SMN2 (0.57) GAAMEN1KMT2ADRD2DRD3
SCHEMBL29598834 0.84 GAA (0.65) GAAMEN1KMT2ADRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1451160-B1 PYRAZOLE-AMIDES FOR USE IN THE TREATMENT OF PAIN ICAGEN INC (US) 2010-01-13 EP claimed
CN-117074579-B Analysis method of related substances of amisulpride oral solution 江苏东科康德药业有限公司 2023-12-22 CN disclosed
CN-117074579-A Analysis method of related substances of amisulpride oral solution 江苏东科康德药业有限公司 2023-11-17 CN disclosed
CN-116836093-A 4-amino-5-alkylsulfinyl-2-methoxybenzoic acid compound and preparation method and application thereof 江苏恩华药业股份有限公司 2023-10-03 CN disclosed
CN-114401717-A Modified release formulations and uses thereof 赛诺维信制药公司 2022-04-26 CN disclosed
CN-112236138-A Crystalline forms and methods of making the same 赛诺维信制药公司 2021-01-15 CN disclosed
CN-112118838-A Non-racemic mixtures and uses thereof 赛诺维信制药公司 2020-12-22 CN disclosed
EP-3720435-A1 CRYSTAL FORMS AND PRODUCTION METHODS THEREOF Sunovion Pharmaceuticals Inc. (US) 2020-10-14 EP disclosed
WO-2019113084-A1 CRYSTAL FORMS AND PRODUCTION METHODS THEREOF SUNOVION PHARMACEUTICALS INC. (US) 2019-06-13 WO disclosed
WO-2011103448-A1 METHODS AND COMPOSITIONS FOR TREATING PSYCHOTIC DISORDERS USING ANTIPSYCHOTIC COMBINATION THERAPY MEDIVATION TECHNOLOGIES, INC. (US) 2011-08-25 WO disclosed
EP-1451160-B1 PYRAZOLE-AMIDES FOR USE IN THE TREATMENT OF PAIN ICAGEN INC (US) 2010-01-13 EP disclosed
CN-1252720-A Gastric-retained pharmaceutical compositions SANOFI SYNTHELABO (FR) 2000-05-10 CN disclosed
EP-0037990-A1 Phenyl quinolizidines, corresponding pharmaceutical preparations, the preparation of the active compounds and corresponding starting compounds F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1981-10-21 EP disclosed
US-3975434-A Processes of producing 2,5-disubstituted benzamides SOCIETE D'ETUDES SCIENTIFIQUES ET INDUSTRIELLES DE L'ILE-DE-FRANCE (FR) 1976-08-17 US disclosed